Measles & Rubella Initiative

Measles & Rubella Initiative
Name	Measles & Rubella Initiative
Formation	2001
Type	Global health partnership
Focus	Measles and Rubella elimination
Headquarters	Washington, D.C., United States
Region served	Worldwide
Key people	(Partners include World Health Organization, UNICEF, American Red Cross, U.S. Centers for Disease Control and Prevention, United Nations Foundation)
Website	measlesrubellainitiative.org

Measles & Rubella Initiative. It is a global partnership committed to ensuring no child dies from measles or is born with congenital rubella syndrome. Founded in 2001, the partnership leverages the resources and expertise of leading health and humanitarian organizations to achieve and sustain measles and rubella elimination. Its work is a cornerstone of global vaccination efforts and a critical component of strengthening national immunization systems worldwide.

History and establishment

The partnership was launched in 2001 as the Measles Initiative, a direct response to the persistent and deadly toll of measles, particularly across Africa and parts of Asia. Key founding partners included the American Red Cross, the U.S. Centers for Disease Control and Prevention, UNICEF, the United Nations Foundation, and the World Health Organization. Its creation was catalyzed by a landmark 2001 World Health Assembly resolution urging accelerated measles control. A major early success was the partnership's support for massive supplementary immunization activities in sub-Saharan Africa, dramatically reducing mortality. In 2012, the initiative expanded its scope to include rubella, formally becoming the Measles & Rubella Initiative, aligning with the World Health Organization's goal of eliminating both diseases in multiple regions.

Goals and objectives

The primary goal is the global elimination of measles and rubella. This is pursued through objectives centered on achieving and maintaining high population immunity through routine immunization and strategic supplemental campaigns. A core aim is to reduce global measles mortality by 95% from pre-vaccine era estimates and to prevent congenital rubella syndrome in all World Health Organization regions. The partnership also works to establish effective disease surveillance and outbreak response systems in every country. These objectives are closely tied to the broader targets of the Global Vaccine Action Plan and support progress toward the Sustainable Development Goals.

Key activities and strategies

The partnership's work is implemented through several key strategies. It provides technical and financial support to countries for planning and executing high-quality supplementary immunization activities, often reaching tens of millions of children in a single campaign. A major focus is strengthening routine immunization systems by training health workers, improving vaccine supply chains like those managed by UNICEF, and supporting new vaccine introductions. The initiative also invests in building robust epidemiological surveillance, including laboratory networks for confirming cases through institutions like the U.S. Centers for Disease Control and Prevention. Furthermore, it engages in global advocacy to sustain political commitment and resource mobilization for immunization.

Partnerships and governance

The initiative operates as a coordinated partnership of five core organizations: the American Red Cross, the U.S. Centers for Disease Control and Prevention, UNICEF, the United Nations Foundation, and the World Health Organization. Governance is provided by a Steering Committee with representation from each core partner. It also collaborates extensively with Gavi, the Vaccine Alliance, the Bill & Melinda Gates Foundation, and national governments, such as those of the United Kingdom and Japan. This multi-stakeholder model allows for the integration of expertise in community mobilization, logistics, policy, science, and fundraising.

Impact and achievements

Since its launch, the partnership's efforts have contributed to a dramatic decline in global measles deaths, estimated to have averted over 56 million deaths between 2000 and 2021. Its support was instrumental in helping the World Health Organization's Region of the Americas achieve measles elimination in 2016. The initiative has supported the vaccination of over 2.9 billion children in more than 90 countries through mass campaigns. Furthermore, over 100 countries have now introduced the rubella vaccine with its support, significantly reducing the incidence of congenital rubella syndrome. These achievements are documented in publications like the Morbidity and Mortality Weekly Report.

Challenges and future directions

Significant challenges remain, including persistent inequities in vaccine access, disruptions from events like the COVID-19 pandemic, and the rise of vaccine hesitancy in some communities. Future directions focus on closing immunity gaps through targeted catch-up campaigns, integrating measles and rubella vaccination with other primary health services, and innovating surveillance technologies. The partnership continues to advocate for sustained financing and political will, aiming to achieve regional elimination goals as outlined by the World Health Organization and ultimately realize a world free of measles and rubella.

Category:Global health organizations Category:Vaccination Category:World Health Organization